逆针“丰隆”穴对大鼠肥胖的预防作用及对转录因子过氧化物酶体增值物激活受体γ的影响

doi:10.12114/j.issn.1007-9572.2018.00.290

摘要/Abstract

摘要： 背景　目前疾病医学逐渐出现向健康医学转变的趋势，医学干预的切入点逐渐提前。“治未病”是中医预防医学思想的重要体现，而逆针灸是其重要手段之一。目的　观察逆针“丰隆”穴对大鼠肥胖的预防作用及对转录因子过氧化物酶体增值物激活受体γ（PPAR-γ）的影响。方法　研究时间为2016年5—7月。将4周龄SPF级雄性大鼠24只随机分为空白组、模型组和逆针组，每组8只。模型组和逆针组进行高脂饲料喂养，空白组进行普通饲料喂养，为期12周，造模同时进行针刺干预，逆针组大鼠固定在自制固定器上，待大鼠平静后，逆针双侧“丰隆”穴区域每周3次，空白组和模型组同步抓取固定，不干预。干预期间每周测量并记录各组大鼠体质量，干预12周后检测各组大鼠肾周脂肪组织重量、脂肪细胞形态学、血清瘦素水平及脂肪组织中转录因子PPAR-γ表达水平。结果　干预第8周，模型组大鼠体质量高于空白组（P<0.05）；干预第12周，模型组、逆针组大鼠体质量高于空白组（P<0.05），逆针组大鼠体质量小于模型组（P<0.05）。模型组、逆针组大鼠肾周脂肪组织重量大于空白组（P<0.05）；逆针组大鼠肾周脂肪组织重量低于模型组（P<0.05）。模型组大鼠脂肪细胞面积较空白组大鼠明显增大，新生脂肪细胞较多；逆针组大鼠脂肪细胞较模型组明显面积减小，新生脂肪细胞较少；模型组大鼠脂肪细胞平均面积大于空白组、逆针组（P<0.05）。模型组大鼠血清瘦素水平高于空白组（P<0.01）；逆针组大鼠血清瘦素水平低于模型组（P<0.01）。模型组大鼠脂肪组织中转录因子PPAR-γ表达水平高于空白组（P<0.05）；逆针组大鼠脂肪组织中转录因子PPAR-γ表达水平低于模型组（P<0.05）。结论　逆针“丰隆”穴可以有效预防大鼠肥胖，改善脂肪代谢的异常状态，其机制可能与改善瘦素抵抗及调节脂肪组织中PPAR-γ的表达有关。

关键词: 肥胖；针灸疗法；穴, 丰隆

Abstract: Background　At present，disease medicine is gradually changing to health medicine，and the time point of medical intervention is gradually getting earlier. Preventive treatment of disease is an important manifestation of TCM preventive medicine，and preventive acupuncture and moxibustion is one of its important means.Objective　To observe the effect of preventive acupuncture at the Fenglong acupoint on obesity prevention and PPAR-γ expression level in rats fed a high-fat diet.Methods　This study was implemented during May to July 2016.Twenty-four four-week-old male SPF male rats were randomly divided into blank group，model group and preventive acupuncture group，with eight in each.All groups received a 12-week intervention，during this period，the blank group received a normal diet plus being taken and fixed at the self-made fixator（three times a week），the model group received a high-fat diet plus being taken and fixed at the self-made fixator（three times a week），and the preventive acupuncture group received a high-fat diet plus preventive acupuncture treatment（bilateral needling of the Fenglong acupoint after being fixed at the self-made fixator，three times a week）；body weight was measured once a week.When the intervention ended，the rats were scarified and perirenal fat weight was measured，morphology of the adipocyte area was observed，serum leptin and PPAR-γ expression levels in the adipose tissue were measured.Results　At the end of the 8th week of intervention，the blank group showed much lower body weight than the model group（P<0.05）．At the end of the intervention，the body weight was much lower in the blank group than that of the model group and preventive acupuncture group（P<0.05）；the preventive acupuncture group demonstrated significantly decreased body weight compared with the model group（P<0.05）.The blank group exhibited significantly decreased perirenal fat weight compared with other two groups （P<0.05）．The perirenal fat weight of the preventive acupuncture group was much lower than that of the model group（P<0.05）．Compared with the model group，both the blank group and preventive acupuncture group showed much less newly generated adipocytes and much smaller adipocyte areas.The average area of adipocytes in model group was larger than that in blank group and preventive acupuncture group （P<0.05）.The model group had significantly higher serum leptin level compared with other two groups（P<0.01）.The PPAR-γ expression level in the adipose tissue in the model group was obviously higher than that of the blank group and preventive acupuncture group （P<0.05）．Conclusion　Preventive acupuncture at the Fenglong acupoint can effectively prevent obesity in rats and improve the abnormal state of fat metabolism.The mechanism may be related to the improvement of leptin resistance and the regulation of PPAR-γ expression level in the adipose tissue.

Key words: Obesity, Acupuncture-moxibustion, Point ST40（Fenglong）

吴佳璟,朱文妍,孙亦农,等. 逆针“丰隆”穴对大鼠肥胖的预防作用及对转录因子过氧化物酶体增值物激活受体γ的影响[J]. 中国全科医学, 2019, 22(6): 707-711. DOI: 10.12114/j.issn.1007-9572.2018.00.290.
WU Jiajing,ZHU Wenyan,SUN Yinong, et al. Effects of Preventive Acupuncture at the Fenglong Acupoint on Obesity Prevention and PPAR-γ Expression Level in Rats Fed a High-fat Diet[J]. Chinese General Practice, 2019, 22(6): 707-711. DOI: 10.12114/j.issn.1007-9572.2018.00.290.

参考文献

［1］ZHANG R Q，TAN J，LI F Y，et al．Acupuncture for the treatment of obesity in adults：a systematic review and meta-analysis［J］．Postgrad Med J，2017，93（1106）：743-751．DOI：10.1136/postgradmedj-2017-134969.
［2］FU S P，HE S Y，XU B，et al．Acupuncture promotes angiogenesis after myocardial ischemia through h3k9 acetylation regulation at VEGF gene［J］．PLoS One，2014，9（4）：e94604．DOI：10.1371/journal.pone.0094604.
［3］HUANG Y，LU S F，HU C J，et al．Electro-acupuncture at Neiguan pretreatment altersgenome-wide gene expressions and protects rat myocardium against ischemia-reperfusion［J］．Molecules，2014，19（10）：16158-16178．DOI：10.3390/molecules191016158.
［4］朱世鹏，陈欢，李晓泓，等．逆针灸作用规律及机制探讨［J］．辽宁中医杂志，2017，44（11）：2450-2454．DOI：10.13192/j.issn.1000-1719.2017.11.069.
ZHU S P，CHEN H，LI X H，et al．Discussion on law of action of preventive acupuncture and moxibustion and it's mechanism［J］．Liaoning Journal of Traditional Chinese Medicine，2017，44（11）：2450-2454．DOI：10.13192/j.issn.1000-1719.2017.11.069.
［5］PARK H K，AHIMA R S.Physiology of leptin：energy homeostasis，neuroendocrine function and metabolism［J］．Metabolism，2015，64（1）：24-34．DOI：10.1016/j.metabol.2014.08.004.
［6］PANARIELLO F，POLSINELLI G，BORLIDO C，et al．The role of leptin in antipsychotic-induced weight gain：genetic and non-genetic factors［J］．J Obes，2012，2012：572848．DOI：10.1155/2012/572848.
［7］SCARPACE P J，MATHENY M，TüMER N，et al．Leptin resistance exacerbates diet-induced obesity and is associated with diminished maximal leptin signalling capacity in rats［J］．Diabetologia，2005，48（6）：1075-1083．DOI：10.1007/s00125-005-1763-x.
［8］GAO A W，CANTó C，HOUTKOOPER R H.Mitochondrial response to nutrient availability and its role in metabolic disease［J］．EMBO Mol Med，2014，6（5）：580-589．DOI：10.1002/emmm.201303782.
［9］SáINZ N，BARRENETXE J，MORENO-ALIAGA M J，et al．Leptin resistance and diet-induced obesity：central and peripheral actions of leptin［J］．Metabolism，2015，64（1）：35-46．DOI：10.1016/j.metabol.2014.10.015.
［10］MAFFEI M，HALAAS J，RAVUSSIN E，et al．Leptin levels in human and rodent：measurement of plasma leptin and ob RNA in obese and weight-reduced subjects［J］．Nat Med，1995，1（11）：1155-1161.
［11］杨春壮，马英，徐永良，等．针刺对单纯性肥胖大鼠血清瘦素含量和下丘脑瘦素受体表达的影响［J］．针刺研究，2007，32（6）：384-388．DOI：10.3969/j.issn.1000-0607.2007.06.007.
YANG C Z，MA Y，XU Y L，et al．Influence of acupuncture on serum leptin level and hypothalamic leptin receptor expression in simple obesity rats［J］．Acupuncture Research，2007，32（6）：384-388．DOI：10.3969/j.issn.1000-0607.2007.06.007.
［12］莫捷，李晓泓，何玉伟，等．逆针灸关元穴对12月龄自然更年期大鼠体质量增长率、下丘脑和卵巢瘦素含量的影响［J］．天津中医药，2010，27（5）：383-385.
MO J，LI X H，HE Y W，et al．Effect of preventive acupuncture and moxibustion at Guan-yuan （CV-4） point on body weight growth rate，leptin level in hypothalamic and ovarian of 12 months old natural climacteric rats［J］．Tianjin Journal of Traditional Chinese Medicine，2010，27（5）：383-385.
［13］PARK K S，KANG I P，SUH H S，et al．The efficacy and safety of acupuncture on serum leptin levels in obese patients：a systematic review and meta-analysis［J］．European Journal of Integrative Medicine，2017，11：45-52.
［14］ISSEMANN I，GREEN S.Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators［J］．Nature，1990，347（6294）：645-650．DOI：10.1038/347645a0.
［15］GRIMALDI P A.The roles of PPARs in adipocyte differentiation［J］．Prog Lipid Res，2001，40（4）：269-281.
［16］EVANS R M，BARISH G D，WANG Y X.PPARs and complex journey to obesity［J］．Nat Med，2004，10（4）：355-361．DOI：10.1038/nm1025.
［17］CHEN J，WANG W，QI Y，et al．Deletion of sphingosine kinase 1 ameliorates hepatic steatosis in diet-induced obese mice：role of PPAR-γ［J］．Biochim Biophys Acta，2016，1861（2）：138-147．DOI：10.1016/j.bbalip.2015.11.006.
［18］LESTARI S R，DJATI M S，RUDIJANTO A，et al．PPAR-γ expression by rambutan peel extract in obesity rat model-induced high-calorie diet［J］．Asian Pacific Journal of Tropical Biomedicine，2015，5（10）：852-857.
［19］RIEUSSET J，TOURI F，MICHALIK L，et al．A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity［J］．Mol Endocrinol，2002，16（11）：2628-2644．DOI：10.1210/me.2002-0036.